Condition
Charles Bonnet Syndrome
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown1
Enrolling By Invitation1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07563101Enrolling By InvitationPrimary
Charles Bonnet Syndrome in Low Vision Patients
NCT04777630CompletedPrimary
Neuroscience of Charles Bonnet Syndrome
NCT05069753Not ApplicableUnknown
Patient Reported Visual Satisfaction Following Same Day or Delayed Bilateral Cataract Surgery
Showing all 3 trials